UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular mechanisms and therapeutic targets in neuroblastoma

Pharmacological research, 2018-05, Vol.131, p.164-176

2018

Volltextzugriff (PDF)

Rho-associated kinase is a therapeutic target in neuroblastoma

Proceedings of the National Academy of Sciences - PNAS, 2017-08, Vol.114 (32), p.E6603-E6612

2017

Volltextzugriff (PDF)

Lithium protects hippocampal progenitors, cognitive performance and hypothalamus-pituitary function after irradiation to the juvenile rat brain

Oncotarget, 2017-05, Vol.8 (21), p.34111-34127

2017

Volltextzugriff (PDF)

Non-surgical relief of cervical radiculopathy through reduction of forward head posture and restoration of cervical lordosis: a case report

Journal of Physical Therapy Science, 2017, Vol.29(8), pp.1472-1474

2017

Volltextzugriff (PDF)

Pharmacological inhibition of BCL-2 with the FDA-approved drug venetoclax impairs longitudinal bone growth

Scientific reports, 2023-05, Vol.13 (1), p.8054-8054, Article 8054

2023

Volltextzugriff (PDF)

Neuroblastoma-A Neural Crest Derived Embryonal Malignancy

Frontiers in molecular neuroscience, 2019, Vol.12, p.9-9

2019

Volltextzugriff (PDF)

Performance in the Blockades of Neoliberalism: Thinking the Political Anew

Wickstrom, M

1, 2012

Volltextzugriff (PDF)

Body surface area-based omega-3 fatty acids supplementation strongly correlates to blood concentrations in children

Prostaglandins, leukotrienes and essential fatty acids, 2021-06, Vol.169, p.102285-102285, Article 102285

2021

Volltextzugriff (PDF)

Screening for phenotype selective activity in multidrug resistant cells identifies a novel tubulin active agent insensitive to common forms of cancer drug resistance

BMC cancer, 2013-08, Vol.13 (1), p.374-374, Article 374

2013

Volltextzugriff (PDF)

The Process of Systemic Change in Filial Therapy: A Phenomenological Study of Parent Experience

Contemporary family therapy, 2009-09, Vol.31 (3), p.193-208

Amy Wickstrom, M. F. T.

2009

Volltextzugriff (PDF)

Phenotype-based drug screening in primary ovarian carcinoma cultures identifies intracellular iron depletion as a promising strategy for cancer treatment

Biochemical pharmacology, 2011, Vol.82 (2), p.139-147

2011

Volltextzugriff (PDF)

GIT1 protects against breast cancer growth through negative regulation of Notch

Nature communications, 2022-03, Vol.13 (1), p.1537-1537, Article 1537

2022

Volltextzugriff (PDF)

Omega-3 fatty acids decrease CRYAB, production of oncogenic prostaglandin E2 and suppress tumor growth in medulloblastoma

Life sciences (1973), 2022-04, Vol.295, p.120394-120394, Article 120394

2022

Volltextzugriff (PDF)

Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance

Nature communications, 2015-11, Vol.6 (1), p.8904, Article 8904

2015

Volltextzugriff (PDF)

Names of stratigraphic units in Swedish

GFF, 2024

2024

Volltextzugriff (PDF)

The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo

Molecular cancer therapeutics, 2007-09, Vol.6 (9), p.2409-2417

2007

Volltextzugriff (PDF)

The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironment

Frontiers in pharmacology, 2023, Vol.14, p.1183720-1183720

2023

Volltextzugriff (PDF)

Targeting Fibroblast Growth Factor Receptor (FGFR) and Phosphoinositide 3-kinase (PI3K) Signaling Pathways in Medulloblastoma Cell Lines

Anticancer research, 2020-01, Vol.40 (1), p.53-66

2020

Volltextzugriff (PDF)

Melflufen - a peptidase-potentiated alkylating agent in clinical trials

Oncotarget, 2017-09, Vol.8 (39), p.66641-66655

2017

Volltextzugriff (PDF)

Effects of PI3K and FGFR inhibitors alone and in combination, and with/without cytostatics in childhood neuroblastoma cell lines

International journal of oncology, 2021-02, Vol.58 (2), p.211-225

2021

Volltextzugriff (PDF)

Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo

International journal of cancer, 2013-04, Vol.132 (7), p.1516-1524

2013

Volltextzugriff (PDF)

Analyses of FGFR3 and PIK3CA mutations in neuroblastomas and the effects of the corresponding inhibitors on neuroblastoma cell lines

International journal of oncology, 2019-12, Vol.55 (6), p.1372-1384

2019

Volltextzugriff (PDF)

MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner

Cancer research communications, 2022-03, Vol.2 (3), p.182-201

2022

Volltextzugriff (PDF)

1 – 25 von 670

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(540)
Mit Volltextzugriff
(579)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Molecular mechanisms and therapeutic targets in neuroblastoma

Rho-associated kinase is a therapeutic target in neuroblastoma

Lithium protects hippocampal progenitors, cognitive performance and hypothalamus-pituitary function after irradiation to the juvenile rat brain

Non-surgical relief of cervical radiculopathy through reduction of forward head posture and restoration of cervical lordosis: a case report

Pharmacological inhibition of BCL-2 with the FDA-approved drug venetoclax impairs longitudinal bone growth

Neuroblastoma-A Neural Crest Derived Embryonal Malignancy

Performance in the Blockades of Neoliberalism: Thinking the Political Anew

Body surface area-based omega-3 fatty acids supplementation strongly correlates to blood concentrations in children

Screening for phenotype selective activity in multidrug resistant cells identifies a novel tubulin active agent insensitive to common forms of cancer drug resistance

The Process of Systemic Change in Filial Therapy: A Phenomenological Study of Parent Experience

Phenotype-based drug screening in primary ovarian carcinoma cultures identifies intracellular iron depletion as a promising strategy for cancer treatment

GIT1 protects against breast cancer growth through negative regulation of Notch

Omega-3 fatty acids decrease CRYAB, production of oncogenic prostaglandin E2 and suppress tumor growth in medulloblastoma

Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance

Names of stratigraphic units in Swedish

SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma

The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo

The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironment

Targeting Fibroblast Growth Factor Receptor (FGFR) and Phosphoinositide 3-kinase (PI3K) Signaling Pathways in Medulloblastoma Cell Lines

Melflufen - a peptidase-potentiated alkylating agent in clinical trials

Effects of PI3K and FGFR inhibitors alone and in combination, and with/without cytostatics in childhood neuroblastoma cell lines

Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo

Analyses of FGFR3 and PIK3CA mutations in neuroblastomas and the effects of the corresponding inhibitors on neuroblastoma cell lines

MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner

Suchergebnisse filtern